Black Bird Biotech Inc (BBBT)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Black Bird Biotech Debt to Equity Ratio: -0.7985 for Sept. 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.7985 |
| June 30, 2023 | -0.822 |
| March 31, 2023 | -0.9688 |
| December 31, 2022 | -1.030 |
| September 30, 2022 | -0.9961 |
| June 30, 2022 | -1.220 |
| March 31, 2022 | -1545.61 |
| December 31, 2021 | 0.087 |
| September 30, 2021 | 0.6897 |
| June 30, 2021 | 1.484 |
| March 31, 2021 | 3.573 |
| December 31, 2020 | 1.652 |
| September 30, 2020 | 3.111 |
| June 30, 2020 | 0.7757 |
| March 31, 2020 | 0.0637 |
| December 31, 2019 | -0.7666 |
| September 30, 2019 | -0.7724 |
| June 30, 2019 | -0.7754 |
| March 31, 2019 | -0.7691 |
| December 31, 2018 | -0.7774 |
| September 30, 2018 | -0.7883 |
| June 30, 2018 | -0.7885 |
| March 31, 2018 | -0.7942 |
| December 31, 2017 | -0.794 |
| September 30, 2017 | -0.7947 |
| Date | Value |
|---|---|
| June 30, 2017 | -0.8072 |
| March 31, 2017 | -0.8098 |
| December 31, 2016 | -0.8252 |
| September 30, 2016 | -0.8402 |
| June 30, 2016 | -0.8444 |
| March 31, 2016 | -0.8306 |
| December 31, 2015 | -0.8365 |
| September 30, 2015 | -0.8459 |
| June 30, 2015 | -0.8619 |
| March 31, 2015 | -0.8672 |
| December 31, 2014 | -0.8788 |
| September 30, 2014 | -0.8777 |
| June 30, 2014 | -0.8807 |
| March 31, 2014 | -0.8865 |
| December 31, 2013 | -0.8947 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | -0.896 |
| September 30, 2012 | -0.9084 |
| June 30, 2012 | -0.9141 |
| March 31, 2012 | -0.9674 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | -1.188 |
| June 30, 2011 | -1.277 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1545.61
Minimum
Mar 2022
3.573
Maximum
Mar 2021
-85.68
Average
-0.7695
Median
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.0988M |
| Total Liabilities (Quarterly) | 1.022M |
| Shareholders Equity (Quarterly) | -0.9228M |
| Current Ratio | 0.0895 |
| Net Debt Paydown Yield | -14.27% |